By A Mystery Man Writer
6th Asia Dengue Summit Recordings
As Philippines seeks Covid-19 vaccines, ghost of Dengvaxia controversy lingers
Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial - ScienceDirect
Dr Lulu Bravo : A New Dengue Vaccine
Knowledge Exchange - ProMED-mail
Meet the Speakers : ASVAC 2023
Clinical Advances in Dengue Control: Pushing Back the Frontiers -- Diagnosis, Treatment, and Prevention
Economic Cost and Burden of Dengue in the Philippines in: The American Journal of Tropical Medicine and Hygiene Volume 92 Issue 2 (2015)
Role of NS1 antibodies in the pathogenesis of acute secondary dengue infection